The Long Run with Luke Timmerman
A podcast by Timmerman Report
173 Episodio
-
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader
Pubblicato: 26/07/2021 -
Ep94: Jenny Rooke on Investing in Biotech Tools
Pubblicato: 19/07/2021 -
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists
Pubblicato: 14/06/2021 -
Ep92: Brad Gray on Spatial Biology
Pubblicato: 01/06/2021 -
Ep91: Daphne Zohar on Biotech Entrepreneurship
Pubblicato: 03/05/2021 -
Ep90: James Sabry on Partnering Amid Scientific Abundance
Pubblicato: 19/04/2021 -
Ep89: Emily Leproust on DNA Synthesis at Scale
Pubblicato: 29/03/2021 -
Ep88: Amy DuRoss on software and logistics for cell and gene therapy
Pubblicato: 15/03/2021 -
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing
Pubblicato: 01/03/2021 -
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease
Pubblicato: 09/02/2021 -
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants
Pubblicato: 20/01/2021 -
Ep84: Steve Paul on Treatments for Mental Health
Pubblicato: 22/12/2020 -
Ep83: David Lee on Impact in Pharmaceuticals
Pubblicato: 14/12/2020 -
Ep82: Andrew Farnum on Medicines From Unusual Traits
Pubblicato: 23/11/2020 -
Ep81: Simba Gill on Microbiome Therapies
Pubblicato: 12/11/2020 -
Ep80: Peter Kolchinsky on Pharma's Soul
Pubblicato: 28/10/2020 -
Ep79: Daphne Koller on Machine Learning for Drug Discovery
Pubblicato: 26/10/2020 -
Ep78: Pearl Huang on Exoneural Cancer Biology
Pubblicato: 13/10/2020 -
Ep77: Jennifer Petter on Drugging RNA Targets
Pubblicato: 29/09/2020 -
Ep76: Otello Stampacchia on Becoming a Biotech VC
Pubblicato: 08/09/2020
"The Long Run" Antarctic explorer Ernest Shackleton would appreciate today's biotech. Scientific entrepreneurs of the 21st century must be ready for what Shackleton called the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina and resilience to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous. Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
